Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Mar 31, 2021 6:26pm
244 Views
Post# 32919573

RE:RE:RE:RE:Bravo! Leede Jones Gable

RE:RE:RE:RE:Bravo! Leede Jones Gable
steadfast wrote: Yes, I will always remember the morning of January 18, 2021 when SVA hit $2.87 and
Dr. Doug Loe's Analyst report was released with a Target of $2.50, SVA has been
declining ever since.  SVA was finally reaching the Cusp of Success, Dr Witkowski's
announcement was greeted with roaring success.  Dr. Toleikis Science was proving very
optimistic.  Chris Temple wrote an outstanding report to his clients, The Profiteer wrote a report forecasting $5.50 potential.  It really looked like $4.00 was imminent and of course there would be some consolidation.
Then we got hit with a PP for $1.20 and the participants shorting the stock.  It has
been a nightmare.  No sense crying over spilled milk.  I don't know if Dr W's
presentation June 28th can get us back to $2.87 as the Momentum has gone.
Volume has dried up,

Dr  T  needs to pull  a rabbit out of the hat before AGM.  The ball is in his court.



Steadfast seems like you have been diagnosed with PTSD after the financing . Not post traumatic distress syndrome but PHilip Tolekis S%$T deal syndrome.  The cure :  exercise your right to vote as a shareholder.  

<< Previous
Bullboard Posts
Next >>